中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
热门
Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy

文献类型:期刊论文

作者Li, Tian-tian1; Zhang, Xiao-hui2; Jing, Jing-feng1; Li, Xin1; Yang, Xiao-qian1; Zhu, Feng-hua1; Tang, Wei1; Zuo, Jian-ping1,2
刊名ACTA PHARMACOLOGICA SINICA
出版日期2015-02
卷号36期号:2页码:188-199
关键词SM934 artemisinin prednisolone membranous nephropathy passive Heymann nephritis proteinuria podocyte renal fibrosis TGF beta 1 Smad epithelial-mesenchymal transition
ISSN号1671-4083
DOI10.1038/aps.2014.134
文献子类Article
英文摘要Aim: SM934 is a novel water-soluble artemisinin derivative with immunoregulatory activities that has been used to treat murine lupus nephritis. In the current study, we investigated the effects of SM934 on rat experimental membranous nephropathy. Methods: Passive Heymann nephritis (PHN) was induced in SD rats by intraperitoneal injection of anti-Fx1A serum. The rats were orally administered SM934 (12.5 and 25 mg.kg(-1).d(-1)) or prednisolone (5 mg.kg(-1).d(-1)) for 28 d. Blood and urine sample, and kidney tissue were collected for analyses. Human complement C3a-induced injury of HK-2 cells was used for in vitro experiments. Results: Treatment of PHN rats with SM934 or prednisolone attenuated the progression of glomerulonephritis and renal fibrosis, as evidenced by the reduced level of proteinuria and circulating antibodies, as well as by the reduced immune complex deposition, reversed podocyte injuries, and attenuated tubulointerstitial fibrosis in the kidneys. Furthermore, the two drugs suppressed TGF-beta 1 expression and Smad2/3 phosphorylation, and increased Smad7 expression in the kidneys. The two doses of SM934 produced almost identical therapeutic effects on PHN rats. Pretreatment with SM934 or a C3a receptor antagonist blocked the C3a-induced epithelial-mesenchymal transition in HK-2 cells in vitro. Conclusion: SM934 ameliorates kidney injury and attenuates the tubulointerstitial fibrosis in PHN rats by down-regulation of the TGF-beta 1 Smad signaling pathway.
WOS关键词CISPLATIN-INDUCED NEPHROTOXICITY ; TUBULAR EPITHELIAL-CELLS ; HEYMANN NEPHRITIS ; MESENCHYMAL TRANSITION ; TGF-BETA ; EXPRESSION ; INJURY ; GLOMERULONEPHRITIS ; INFLAMMATION ; MECHANISM
资助项目National Natural Science Foundation of China (NSFC)[81273524] ; National Natural Science Foundation of China (NSFC)[81322049] ; National Natural Science Foundation of China (NSFC)[81273525] ; National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China[2014ZX09101002] ; National Key Basic Research Programme (973 Programme)[2014CB541906]
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
CSCD记录号CSCD:5351051
WOS记录号WOS:000349333700005
出版者ACTA PHARMACOLOGICA SINICA
源URL[http://119.78.100.183/handle/2S10ELR8/276655]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Tang, Wei
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
2.Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Li, Tian-tian,Zhang, Xiao-hui,Jing, Jing-feng,et al. Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy[J]. ACTA PHARMACOLOGICA SINICA,2015,36(2):188-199.
APA Li, Tian-tian.,Zhang, Xiao-hui.,Jing, Jing-feng.,Li, Xin.,Yang, Xiao-qian.,...&Zuo, Jian-ping.(2015).Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.ACTA PHARMACOLOGICA SINICA,36(2),188-199.
MLA Li, Tian-tian,et al."Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy".ACTA PHARMACOLOGICA SINICA 36.2(2015):188-199.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。